Cargando…
A comparison between patients who suffer from major depression and are treated with Esketamine – one group participates in group therapy and the other one does not
INTRODUCTION: Major depressive disorder is present in approximately 7% of the general population. There are some patients that remain treatment-resistant - patients who were treated with two or more different medications and did not demonstrate any improvement in their mental state. These patients c...
Autores principales: | Yaniv, H., Savlev, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566977/ http://dx.doi.org/10.1192/j.eurpsy.2022.1436 |
Ejemplares similares
-
Therapy group following a Ketamine treatment – a case report of a patient with resistant depression
por: Yaniv, H., et al.
Publicado: (2022) -
Electroconvulsive therapy vs Esketamine among patients with Major Depressive Episode
por: Basto, M. D. R. D. R. F. D. A., et al.
Publicado: (2023) -
The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021) -
Treating with esketamine nasal, will increase blood pressure?
por: Rosello-Molina, V., et al.
Publicado: (2021) -
How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)